Bausch + Lomb CEO Brent Saunders abruptly departs after failed multibillion-dollar sale
read at Endpoints ↗Negative
Brent Saunders, known as a leading dealmaker and one of the highest-paid executives in biopharma, has left his role as chief executive of Bausch + Lomb.
His departure ends a second stint as CEO of the eye-care company, a position he held after previously leading the firm.
Saunders' tenure did not produce another multibillion-dollar company sale, a benchmark that had been expected given his track record.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Brent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year run”
read at Endpoints ↗92 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that